Forensic Technology Market Worth $40.4 Billion By 2025

The global forensic technology market size is expected to reach USD 40.4 billion by 2025, according to a new report by Grand View Research, Inc. Innovations in forensic science lead to the development of advanced techniques for solving crimes and increasing the efficiency of DNA testing. Government initiatives for achieving progress in research in forensic science, which is critical for public safety, is widening the scope for forensic technology market growth. For instance, the National Institute of Justice (NIJ) entered into a partnership with the National Institute of Standards and Technology (NIST), and National Science Foundation (NSF) to develop new techniques.

These organizations have also jointly initiated the Industry/University Cooperative Research Centers Program that aids in industry and academic collaborations for efficient R&D in forensic science. One of the major contributions by this program includes the development of practices for preservation and handling of DNA &other biological evidence. These agenda of this program is to enhance the interoperability of national as well as regional automated fingerprinting identification systems, limit investigator bias, and develop standards for efficient analysis in criminal cases.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/forensic-technology-market

Further Key Findings From the Report Suggest:

Capillary electrophoresis accounted for the largest part of the type segment in 2016. This can be attributed to high penetration in various applications such as toxicology studies, illicit drug analysis, and ballistics
In the services segment, chemical analysis captured the dominant share in 2016. This is a result of increasing adoption of this technique in fire debris analysis, serology, bloodstain pattern analysis, and fingerprinting
In the application segment, judicial/law enforcement held the largest part in 2016 owing to the growing number of government initiatives intended toward clearing backlogs of criminal cases that require concrete evidence
Laboratory technology held a substantial share of the location segment. This is a consequence of consistent usage due to its ability to analyze a large number of samples
North America held the largest share of the market owing to the increase in the number of supportive government initiatives aimed toward promoting the usage of forensic technologies
Asia Pacific is anticipated to witness lucrative CAGR during the forecast period. The lucrative growth rate can be attributed to the development of advanced infrastructure for testing facilities
High competition has been observed as a result of key players adopting strategies that include new product development and strategic collaborations & agreements to gain competitive advantage

mHealth Apps Market Size Worth $236.0 Billion By 2026

The global mHealth apps market size is expected to reach USD 236.0 billion by 2026, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 44.7% during the forecast period. The market is majorly driven by increasing adoption of advanced technologies in healthcare facilities and the need to reduce long waiting periods to access healthcare facilities from specialists. Availability of mobile applications for users is witnessing a rapid growth, especially healthcare apps that assist consumers in self-management of disease, wellness, and chronic conditions. This increased role of patients coupled with the rising importance in staying updated and informed about their own healthcare decisions, contributing to the rise in adoption of mHealth apps globally.

Healthcare industry has been transitioning towards a value-based care model with mHealth becoming a widespread trend owing to the advent of technologies such as remote monitoring, electronic medical record, and other communication platforms. The increasing prevalence of disorders, such as diabetes, hypertension, cancer, and obesity along with the growing awareness about wellness and other preventive measures diseases among patients is expected to boost the mHealth market growth.

mHealth leverages from the 4Ps: personalized, predictive, participatory, and preventive measures for care delivery to provide optimal care to users. Moreover, rising penetration of smartphones, and other electronic devices, especially, in low- and middle-income countries and increasing focus on the use of mobile technology to manage care delivery is anticipated to benefit the market.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/mhealth-app-market

Further key findings from the report suggest:

Rapid growth in chronic diseases along with the rise in the number of app users is accountable for the mHealth apps market growth
The types of mHealth apps include fitness, lifestyle management, nutrition and diet, women’s health, medication adherence, healthcare providers, and disease management. Of these, the fitness category accounted for the majority of segment share in 2018
mHealth app vendors are focusing their attention on women’s health, diet, and medication reminders. According to Wired, a mobile advertising and analytics platform, women are more inclined toward tracking their health than men
Physicians are increasingly recommending the use of mHealth apps to their patients, which is likely to increase the adoption rate of mHealth apps
North America led the mhealth applications market in 2018 in terms of revenue share pertaining to the technological advancements and presence of major players in the region
Some of the key players are Johnson & Johnson; Abbott Laboratories; AstraZeneca; Bristol-Myers Squibb Company; F. Hoffmann-La Roche Ltd; Novartis AG; GlaxoSmithKline plc; Merck and Co., Inc.; Pfizer; and Sanofi

qPCR & dPCR Market Size Worth $4.33 Billion By 2026

The global real-time pcr and digital pcr market size is anticipated to reach USD 4.33 billion by 2026, according to a new report by Grand View Research, Inc. It is anticipated to register a CAGR of 8.5% during the forecast period. Growing demand for Rapid Diagnostics Tests (RTDs) is one of the high impact rendering drivers for this market. The demand for RDTs is likely to witness strong growth as local governments across the globe seek to incorporate these tests to improve the diagnosis and treatment of infectious diseases.

The emergence of RDTs as an important tool in the management of infectious diseases owing to the ability to provide rapid results in remote areas with limited healthcare infrastructure is likely to fuel the growth of the Polymerase Chain Reaction (PCR) systems which are used extensively to conduct these diagnostic procedures.

In addition, high prevalence of infectious diseases is one of the major factors contributing to the market growth. According to the estimates by the World Health Organization (WHO), lower respiratory infections, diarrheal diseases, and tuberculosis were ranked among the top ten causes of deaths worldwide in 2016. New cases of other infectious diseases, such as HIV/AIDS and malaria among others continue to witness sharp increase in developing countries which is expected to substantially increase the patient population, driving the need for better diagnosis options.

Furthermore, inorganic growth strategies such as mergers and acquisitions employed by major PCR manufacturers to broaden their product portfolio and to develop novel qPCR and dPCR products is another factor expected to propel the market during the forecast period. For instance, in January 2017, RainDance Technologies, Inc. was acquired by Bio-Rad Laboratories, Inc. which is expected to strengthen the company’s position in the field of droplet digital PCR and next generation sequencing.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/real-time-pcr-qpcr-digital-pcr-dpcr-market

Further key findings from the study suggest:

qPCR held the largest market share in 2018 due to the accuracy and wide applications of the technology in quantification of gene expression, pathogen detection and microRNA analysis
Digital PCR is estimated to be the fastest growing segment due to precise quantification of target sequences
Consumables and reagents led the product segment and is likely register the fastest CAGR of 8.9% over the forecast period due strong uptake in the use of PCR kits in diagnostic tests
Research application was the largest segment in terms of value in 2018, due to wide-spread use in research areas, such as stem cells, microbiology, and agriculture
Clinical application is expected to witness robust growth over the forecast period due to the adoption of automated processes
North America held the largest market share in terms of revenue in 2018 due launch of new PCR products along with rising demand for rapid diagnostic tests
Asia Pacific is projected to register comparatively strong growth during the forecast period owing to burgeoning patient population as a result of prevalence of infectious diseases
Prominent players in the qPCR and dPCR market include Bio-Rad Laboratories; Thermo Fisher Scientific Inc.; Qiagen N.V.; Abbott Laboratories, Inc.; and others

Transplantation Market Size Worth $25.8 Billion By 2027

The global transplantation market size is expected to reach USD 25.8 billion by 2027, growing at a CAGR of 9.3%, according to a new report by Grand View Research, Inc. Growing cases of organ failure have resulted increased demand for transplantation procedures. Rising demand for tissue products, immunosuppressants, and organ preservation solutions is a major factor anticipated to boost the market growth during forecast period. Thus, many biotechnology and medical device manufacturing companies are concentrating on the development of advanced transplant products.

Technological advancement in organ transplantation methods is another key factor supporting the market growth. Introduction of advanced tissue products, such as DeNovo NT Graft, Chondrofix Osteochondral Allograft, and DuraMatrix Collagen Dura Substitute Membrane provides higher benefits during treatment. In addition, computerized support systems with advanced systems and software allow easy & effective maintenance of tissues. Thus, availability of such advanced techniques supports market growth.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/transplantation-market

Further key findings from the report suggest:

Tissue products was the largest revenue-generating segment due to rising demand for tissue and organ transplant procedures
Tissue products segment is expected to expand further at a significant CAGR owing to advancement in transplantation products
The transplant centers end-use segment is projected to register the highest CAGR during the forecast period owing to rising popularity of these centers for transplant procedures
The hospitals segment led the market in 2019, in terms of revenue, owing to a large number of transplant procedures performed in hospitals
North America was the leading regional market in 2019 and is projected to maintain its dominance during the forecast period owing to well-developed healthcare infrastructure
Moreover, presence of a large number of research laboratories, biotechnology, and medical devices manufacturing companies in North America is projected to contribute to the region’s growth

Oncology Based In-Vivo CRO Market Size Worth $1.5 Billion By 2025

The global oncology based in-vivo CRO market is expected to reach USD 1.5 billion by 2025, according to a new report by Grand View Research, Inc. The use of Contract Research Organization (CRO) oncology services helps the manufacturers/sponsors to provide complete attention on the production capacity and at enhancing their in-house processes.

Furthermore, the pressure from the increasing competition due to patent expirations, rapid growth of generics, and introduction of biosimilar equivalents are propelling the pharmaceutical companies to take the aid of such organizations. Hence, it can be predicted that the oncology based in-vivo CRO market may witness lucrative growth over the forecast period.

Another factor propelling growth is the increasing incidence of cancer, and high failure rate of existing treatment options. According to statistics published by the World Health Organization (WHO), approximately 8.2 million deaths are recorded each year from cancer, which accounts for 13.0% deaths worldwide.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/oncology-based-in-vivo-cro-market

Further key findings from the study suggest:

Based on indication, solid tumors are expected to dominate the market as of 2016. Furthermore, it is anticipated to grow at the fastest CAGR owing to the factors such as growing incidence rate, augmenting research for tumors in organs such as breast, and liver, and technological advancement offered by key industry players.
Solid tumors are analyzed by means of models such as xenograft, Patient Derived Xenografts (PDX), and syngeneic. The PDX models are expected to witness lucrative growth over the forecast period and capture over 40.0% of the market share by 2025.
Geographic expansion into Asia Pacific countries by well-established players is anticipated to promote the fastest growth for the region. India is one the most lucrative country owing to presence of service tax exemption and venture capital based funding for CROs.
Few of the industry players for the oncology based in-vivo CRO market are The Jackson Laboratory, Covance, Taconic Biosciences, Charles River Laboratory, EVOTEC, Wuxi AppTec, and ICON Plc.
A common trend observed is the rising partnerships among CROs to offer bundle packages of services to sponsors. For instance, In May 2017, CRL International, Inc. announced their partnership with OcellO, established in Netherlands. According to this partnership, CRL would be utilizing the latter’s PDX model capabilities in order to expand their oncology based drug discovery service portfolio.

Radiation Oncology Market Worth $11.5 Billion By 2027

The global radiation oncology market size is expected to reach USD 11.5 billion by 2027, according to a new report by Grand View Research, Inc., registering a CAGR of 7.3% over the forecast period. Increasing prevalence of cancer is one of the major factors driving the market growth.

Rising technological advancements in radiation therapy is expected to increase the adoption of radiation oncology. For instance, in April 2019, Accuray Incorporated launched Synchrony motion tracking and correction technology for Radixact system. This technology improves dose accuracy and treatment times and is relatively more effective when compared to conventional radiosurgery therapy systems. Such advancements in technology is expected to boost the market growth.

Key players in the market focus on strategic initiatives such as collaborations, new product developments, and acquisitions. For instance, in August 2019, Mevion Medical Systems and C-RAD integrated MEVION S250i Proton Therapy System and C-RAD Catalyst PT. Integration of these products supports seamless workflow throughout the treatment with patient tracking and monitoring from setup through treatment.

Rising adoption of radiotherapy by medical centers and hospitals is expected to drive the market growth. For instance, according to an article published in Seminars in Radiation Oncology in 2017, it is estimated that more than 12,000 additional treatment machines will be required by 2035 in low- and middle-income countries alone. Furthermore, by 2035, China, India, and Brazil are estimated to require over 3,800; 1,200; and 400 additional machines, respectively.

Key initiatives are being undertaken by the U.S. government to facilitate and support R&D in oncology. Cancer Moonshot, RAS Initiative, and NCI Community Oncology Research Program are some of the initiatives undertaken by the U.S. government and are expected to have a positive impact on market growth.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/radiation-oncology-market

Further key findings from the study suggest:

External Beam Radiation Therapy (EBRT) dominated the radiation oncology market in 2019 owing to high availability and penetration of sophisticated diagnostic tools and increase in awareness about available treatment options
Brachytherapy is projected to account for the largest share through the forecast period due to extensive usage of brachytherapy for the treatment of prostate and breast cancer
EBRT emerged as the largest application segment as this therapy is non-invasive and is used for the treatment of prostate, breast, lung, colorectal, head, and neck cancer owing to its ability to treat cancers in inoperable patients
The growth of the 3-D CRT technology segment is attributed to its precise radiation treatment and ability of radiation beams to form the same shape as the tumor at the specific site of cancer
North America dominated the global market in 2019. Presence of major players, reimbursement policies, and developed health infrastructure are the key factors driving the regional market growth
Key players operating in the market include Accuray, Inc.; Nordion (Canada) Inc.; Varian Medical Systems; IsoRay, Inc.; Ion Beam Applications SA; Elekta AB; C.R. Bard, Inc., Mallinckrodt Public Ltd.; Mevion Medical Systems, and NTP Radioisotopes SOC. Ltd.

Veterinary Surgical Instrument Market Size Worth $1.5 Billion By 2027

The global veterinary surgical instrument market size is expected to reach USD 1.5 billion by 2027, according to a new report by Grand View Research, Inc., registering a CAGR of 7.0% from 2020 to 2027. Growing demand for pet adoption is expected to drive the market over the forecast period. Increasing income in developing countries is another driving factor. For instance, according to a report by the American Veterinary Medical Association (AVMA) in 2017, around 46.0% households had multiple types of pets in U.S. Furthermore, key players are implementing newer strategies to sustain in this competitive market. For instance, in March 2019, Bruhat Bengaluru Mahanagara Palike (BBMP) in India planned to introduce a rescue ambulance to rescue injured animals for faster treatment. The ambulance will be equipped with all the necessary tools such as surgical instruments and sterilizers.

Moreover, technological advancements in surgical devices and availability of a number of detection techniques are anticipated to create growth opportunities in the market. These include micro fracture detection, laparoscopy, and 3D printing. For instance, in October 2017, Surgical Holdings launched two new products-chisels and osteotomes-to expand its product portfolio.

The global veterinary surgical instrument market is highly competitive in nature. It is dominated by participants such as B. Braun Vet Care GmbH, Medtronic, Jorgen Kruuse A/S , and SurgiVet. Market players focus on adopting strategies such as new product launches, partnerships, and collaborations. For instance, in July 2018, B. Braun Vet Care signed an agreement deal with CP Medical wherein the company will distribute B. Braun’s veterinary Infusion Therapy product line in U.S. and Canada.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/veterinary-surgical-instruments-market

Further key findings from the report suggest:

Increasing number of veterinary practitioners are anticipated to create growth opportunities in the market
Handheld devices accounted for the largest share in 2019, owing to their use for multiple purposes and ease of handling
The small animal segment is expected to exhibit lucrative growth over the forecast period owing to rising incidences of pet adoption and increased demand for efficient care
The dental surgery segment held the largest share in 2019 due to increasing prevalence of periodontal diseases and rising demand for pet dental care
North America dominated the global market in 2019 due to favorable pet insurance policies and new product launches by companies. However, Asia Pacific is anticipated to exhibit the most lucrative growth rate over the forecast period owing to the rising demand for pet adoption and increasing disposable income, particularly in Japan and India
Some of the key companies in the market are Medtronic, DRE Veterinary, B. Braun Vet Care GmbH, and Jorgen Kruuse A/S.

Automotive Cyber Security Market Size Worth $5.56 Billion By 2025

The global automotive cyber security market size is expected to reach USD 5.56 billion by 2025 expanding at a CAGR of 21.4% during the forecast period, according to a study conducted by Grand View Research, Inc. Increasing risks of data breaching due to rise in number of connected and automated vehicles will drive the market. Moreover, growing emphasis of OEMs on strengthening cyber security policies is expected to propel the demand for automotive cyber security over the projected period. Cloud infrastructure, mobile cross platforms, and automotive data taxonomy, are the key connectivity trends in the automotive cyber security market.

Technological advancements pertaining to network connectivity in autonomous vehicles are gaining traction owing to increasing data and volume of data exchange, which is also likely to contribute to the market growth. Moreover, onboard electronic information-control systems like tire-pressure, electric power steering, fixed-speed cruise control, and auto-braking sensors have become mandatory across all the vehicle categories. Other sophisticated systems are also making their way into automotive electronics applications, such as infotainment, ADAS, navigation, powertrain, and safety systems. This, in turn, would further increase the vehicle-to-everything communication, thereby creating lucrative growth opportunities for the market in automotive sector.

North America is the largest regional market due to increasing demand for autonomous vehicles and quick adoption of new technologies like smart antenna and connected car systems. Moreover, rising investments and stringent measures taken by the government towards incorporating cyber security policies for the automotive market have bolstered the regional market growth. Some of the prominent industry participants include Vector Informatik GmbH, Arilou Technologies, NXP Semiconductors N.V., Argus Cyber Security Ltd, ESCRYPT, Continental AG, and HARMAN International.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/automotive-cyber-security-market

Further key findings from the report suggest:

The passenger car segment in Europe is expected to account for 77.1% by 2025 due to rising production of Electric Vehicles (EVs), development and implementation of cyber security strategies, eco-friendly initiatives, and growing scope of data exchange
Infotainment application led the market in China due to quick adoption of advanced vehicle technologies
Wireless network security segment is expected to account for the largest share of the global automotive cyber security market by 2025
Emphasis of OEMs on capabilities offered by connected car systems that have enabled a broad range of service and features contributes to growth of the market in developed economies

Medical Devices Reimbursement Market Worth $1169.8 Billion By 2027

The global medical devices reimbursement market size is expected to reach USD 1169.8 billion by 2027, expanding at a CAGR of 10.4%, according to a new report by Grand View Research, Inc. The rising number of regulatory reforms and increasing efforts of healthcare providers to reduce costs and improve the quality of medical equipment are anticipated to propel the market growth. Medical device reimbursement is defined as the payment, a third-party private or public insurer pays to a healthcare provider for the cost incurred while using healthcare equipment.

The major factors fueling market growth are growing dependence on remuneration, increasing prevalence of chronic diseases, and growing preventive care. Rising focus on early diagnostics and preventive care may in turn lead to higher activity within the diagnostic device industry, thus promoting more remuneration share from them. For instance, a fundamental paradigm shift towards incentivizing early diagnosis through remuneration is noticed across developed economies, such as screening for breast cancer.

With the increasing demand for healthcare equipment, the remuneration services are expected to provide various opportunities for healthcare industries to poach upon. Additionally, an increasing number of people pursuing insurance and consolidation of the healthcare system are the major factors fueling the market.

North America held the highest revenue share of about 50.0% in the market in 2019 and is expected to maintain its dominance over the forecast period. Increasing adoption of healthcare devices reimbursement and raising awareness with regards to cost implications are expected to drive the market in the region. In addition, rising demand for healthcare equipment and an increasing number of healthcare centers is expected to drive the market in this region. With increasing chronic diseases, the demand for healthcare equipment is also increasing. As per the National Health Council Report, around 157.0 million people will suffer from multiple chronic conditions until 2020. Due to these reasons, the market is expected to show significant growth over the forecast period.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/medical-devices-reimbursement-market

Further Key Findings From the Study Suggest:

The private player segment dominated the market with a share of 64.7% in 2019 due to the presence of a large number of private players
The hospitals segment dominated the market with a share of 49.6% over the forecast period due to recent technological developments and high patient footfall requiring the use of healthcare equipment
North America is expected to dominate the market over the forecast period owing to strong reimbursement framework
The market in Asia Pacific is projected to witness rapid growth during the forecast period owing to rising penetration of insurance services in rural and urban areas.

Dental Adhesives And Sealants Market Size Worth $6.1 Billion By 2027

The global dental adhesives and sealants market size is expected to reach USD 6.1 billion by 2027, expanding at a CAGR of 18.9%, according to a new report by Grand View Research, Inc. The high demand for dental restorations, an increase in the geriatric population and road accidents, and the wide product range are expected to propel market growth over the forecast period. In addition, technological advancements in dental materials are also expected to increase adoption, thereby contributing to market growth.

The introduction of advanced dental sealants by market players are anticipated to dominate the market strategies adopted for growth. For instance, 3M introduced ‘Clinpro’ sealant which changes its color from pink to off-white upon exposure to light. This color change technology not only improves the accuracy of sealant placement but also aids in determining the amount to be placed. The user-friendliness of such technologies is expected to increase the usage and demand for thin plastic coatings among dentists.

Furthermore, the increasing influence of social media coupled with globalization has led to the convergence of concepts related to beauty, especially those concerning facial features. This has led to a rise in demand for dental cosmetic procedures such as tooth whitening, tooth bonding, and dental veneers, which is anticipated to support market growth. Furthermore, the rapidly aging population in countries such as Japan, the U.K., Germany, and the U.S. are anticipated to increase the requirement of dentures and related products.

North America accounted for the highest market share in 2019 owing to favorable reimbursement framework, growing prevalence of oral diseases, and high demand for cosmetic dentistry in the country. In addition, the presence of major players in the region also contributed to market growth.

In Asia Pacific, the market is anticipated to witness the highest CAGR over the forecast. The growth of the market in the region is attributed to growing awareness regarding oral health, increasing the aging population, and rising cases of tooth decay due to changing lifestyles.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/dental-adhesives-sealants-market

Further key findings from the report suggest:

By product, the adhesives segment held the largest market share in 2019 owing to high product availability and demand for cosmetic dentistry
Restorative adhesives held the largest market share of 58.0% in terms of revenue in 2019 owing to their broad applications and the presence of a broad product portfolio in the market
The resin-based sealant segment accounted for the largest revenue share in 2019 due to the high adoption of these products among dentists
In Asia Pacific, the market is expected to witness the fastest growth rate over the forecast period owing to the growing geriatric population and increase in oral health awareness in the region.